Influenza vaccine production for the U.S. market

Lauren M. Smith, Gigi Gronvall

Research output: Contribution to journal › Article

Abstract

Policymakers will be better prepared to formulate and communicate policies for access to influenza vaccine if they understand the vaccine production process and timeline. In addition to providing background, this article highlights where vaccine production delays may occur. This should be useful for describing vaccine production issues that may be raised by the current 2009 H1N1 pandemic.

Original languageEnglish (US)
Pages (from-to)259-263
Number of pages5
JournalBiosecurity and Bioterrorism
Volume7
Issue number3
DOIs
StatePublished - Sep 1 2009
Externally publishedYes

Fingerprint

influenza
Vaccines
Influenza Vaccines
vaccine
contagious disease
market
production process
Pandemics

ASJC Scopus subject areas

  • Health(social science)
  • Public Health, Environmental and Occupational Health
  • Management, Monitoring, Policy and Law

Cite this

Influenza vaccine production for the U.S. market. / Smith, Lauren M.; Gronvall, Gigi.

In: Biosecurity and Bioterrorism, Vol. 7, No. 3, 01.09.2009, p. 259-263.

Research output: Contribution to journal › Article

Smith, LM & Gronvall, G 2009, 'Influenza vaccine production for the U.S. market', Biosecurity and Bioterrorism, vol. 7, no. 3, pp. 259-263. https://doi.org/10.1089/bsp.2009.0921
Smith LM, Gronvall G. Influenza vaccine production for the U.S. market. Biosecurity and Bioterrorism. 2009 Sep 1;7(3):259-263. https://doi.org/10.1089/bsp.2009.0921
Smith, Lauren M. ; Gronvall, Gigi. / Influenza vaccine production for the U.S. market. In: Biosecurity and Bioterrorism. 2009 ; Vol. 7, No. 3. pp. 259-263.
@article{18a16765542c434aa04502dd3dca21b1,
title = "Influenza vaccine production for the U.S. market",
abstract = "Policymakers will be better prepared to formulate and communicate policies for access to influenza vaccine if they understand the vaccine production process and timeline. In addition to providing background, this article highlights where vaccine production delays may occur. This should be useful for describing vaccine production issues that may be raised by the current 2009 H1N1 pandemic.",
author = "Smith, {Lauren M.} and Gigi Gronvall",
year = "2009",
month = "9",
day = "1",
doi = "10.1089/bsp.2009.0921",
language = "English (US)",
volume = "7",
pages = "259--263",
journal = "Health security",
issn = "2326-5094",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Influenza vaccine production for the U.S. market

AU - Smith, Lauren M.

AU - Gronvall, Gigi

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Policymakers will be better prepared to formulate and communicate policies for access to influenza vaccine if they understand the vaccine production process and timeline. In addition to providing background, this article highlights where vaccine production delays may occur. This should be useful for describing vaccine production issues that may be raised by the current 2009 H1N1 pandemic.

AB - Policymakers will be better prepared to formulate and communicate policies for access to influenza vaccine if they understand the vaccine production process and timeline. In addition to providing background, this article highlights where vaccine production delays may occur. This should be useful for describing vaccine production issues that may be raised by the current 2009 H1N1 pandemic.

UR - http://www.scopus.com/inward/record.url?scp=70350176279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350176279&partnerID=8YFLogxK

U2 - 10.1089/bsp.2009.0921

DO - 10.1089/bsp.2009.0921

M3 - Article

C2 - 19821749

AN - SCOPUS:70350176279

VL - 7

SP - 259

EP - 263

JO - Health security

JF - Health security

SN - 2326-5094

IS - 3

ER -

Access to Document